#United States #New York #Class Action #Pomerantz Law #Reckitt Benckiser

Investor Alert: Reckitt Benckiser Class Action Lawsuit Overview

On June 17, 2025, Pomerantz LLP, a prominent law firm recognized for its litigation excellence, announced a class action lawsuit against Reckitt Benckiser Group Plc (Reckitt), and is urging affected investors to come forward. This legal action is pivotal for those who believe they incurred losses while investing in Reckitt securities.

The claim stems from allegations that Reckitt, along with certain executives, may have engaged in improper business practices, potentially misleading investors regarding the safety and risk associated with some of its products. This class action further adds to Reckitt’s recent legal troubles, notably linked to its Mead Johnson subsidiary, which has previously faced significant verdicts in court regarding the safety of its cow's milk-based formula.

Key Deadlines and Information

Affected investors are advised to reach out to Pomerantz LLP, ideally by contacting Danielle Peyton at [email protected] or by calling 646-581-9980. Additionally, individuals interested in leading the class action have until August 4, 2025, to file for that role. Those who wish to inquire via email are encouraged to provide pertinent personal details such as mailing address, phone number, and information regarding their purchased shares.

Investors are able to access a complete copy of the lawsuit by visiting Pomerantz's website to stay informed about the proceedings.

Recent Legal Precedent

The lawsuit arrives on the heels of a $60 million verdict against Reckitt's Mead Johnson, in which a jury found negligence due to a failure to adequately warn consumers of the risks associated with their baby formula. The ruling specifically indicated that the formula was linked to a higher risk of necrotizing enterocolitis (NEC) among preterm infants. Following this verdict on March 15, 2024, Reckitt’s American Depositary Shares (ADS) experienced a drop of nearly 14%, demonstrating how swiftly the market reacted to news of legal troubles.

Moreover, just a few months later, on July 29, 2024, another jury highlighted similar negligence concerns with Abbott Laboratories regarding its baby formula, leading to a staggering $495 million in damages awarded, subsequently affecting Reckitt’s market position even further when its stock fell again by nearly 9%.

These developments emphasize an ongoing scrutiny surrounding Reckitt, raising questions for investors and stakeholders about the company’s business ethics and transparency.

About Pomerantz LLP

Pomerantz Law Firm, founded over 85 years ago, is acclaimed for its focus on corporate, securities, and antitrust class litigation. With offices across major cities including New York, Chicago, and London, the firm has established a legacy of advocating for victims of corporate misconduct. Its continuing mission is to ensure that investors who are wronged by securities fraud or allegations of fiduciary misconduct are represented with tenacity and care.

Contact Information: For further inquiries, reach out to Danielle Peyton at 646-581-9980 ext. 7980 or email [email protected].

As the situation continues to develop, those affected are encouraged to remain vigilant and proactive in seeking legal counsel to protect their interests.

Conclusion

This class action serves as a crucial reminder for investors to be aware of the companies they support and the potential risks involved. The outcome of the lawsuit against Reckitt may not only impact the company's future but also set a precedent for corporate responsibility and investor protection in the rapidly evolving market landscape.